In coeliac disease many immunological, biochemical, and morphological changes are evident in the jejunal mucosa of patients with villous atrophy. Specific abnormalities associated with the epithelium include changes in enterocyte structure,' brush border enzyme activity,' crypt cell production rate and HLA antigen expression. 4 21 February 1989. intestinal mucosa of patients with coeliac disease and normal subjects during short term in vitro culture.
Methods

COELIAC PATIENTS
Jejunal biopsies were obtained from 26 patients with coeliac disease using a Crosby capsule or a Quinton hydraulic multiple biopsy instrument. Thirteen were untreated (10 women, mean age 39 1 years, range 17-69) on normal diets at the time of biopsy. Jejunal biopsies from these patients showed subtotal villous atrophy on histological examination. Ten of the untreated patients have, to date, shown histological improvement of villous architecture on gluten free diets. The 13 treated coeliac patients (11 women, mean age 36.9 years, range 17-53) who were studied, had been on gluten free diets for a minimum of six months at the time of biopsy. Biopsies from eight patients were histologically normal and five patients had partial villous atrophy.
CONTROL PAIIENTS
Jejunal tissue was obtained from 19 control patients (mean age 34-6 years, range 17-60) undergoing investigation for possible coeliac disease. Multiple biopsies were also obtained from the second part of the duodenum of 39 patients at endoscopy. The duodenal and jejunal mucosae of all control patients were normal at histological examination. and 1% phosphotungstic acid (PTA) at 4°C overnight. After centrifugation ( 10000 g) the precipitate was washed three times with bo0% TCA and l o PTA to remove unlincorporated glucosamine and twice with 1: 1 chlorotorm-methlanol to extract lipids. The dried acid-insoluble precipitate was solubilised in I ml NCS (Amersham) and counted in liquid scintillation solution (Optiphase X) in a Packard Tricarb 4000 liquid scintillation counter. To correct for quenching, the samples were counted against an internal standard and the results expressed as disintegrations per minute per mg biopsy protein (dpm/mg protein).
The secreted radiolabelled glycoproteins were measured by precipitating with 1(% TCA and 1% PTA the glycoproteins in the culture medium and the medium used to rinse the biopsy. The precipitates were processed and counted in a similar manner to tissue glycoproteins TCA-PTA precipitates. Control cultures of radiolabelled medium incubated with no biopsy tissue were similarly processed to correct for non-specific binding of radioactivity to fetal calf serum. Figure 2 . Biopsies from untreated coeliac patients incorporated significantly higher amounts (p<0-05) of radiolabel into tissue glycoproteins than normal or treated coeliac mucosa. The secretion of radiolabelled glycoproteins by untreated coeliac mucosa was also significantly greater than normal (p<0-001) and treated coeliac (p<0-01) tissue. In untreated coeliac mucosa, 39-5% of the 3H glucosamine incorporated into acid precipitable glycoproteins over a 24 hour period was secreted. (p<0-05), being 24% and 27% respectively. There was a significant correlation (p<0-05) between the total H glucosamine incorporation into glycoproteins in histologically normal jejunal tissue and the goblet cell numbers per unit area of mucosa in histological sections of adjacent tissue (Fig. 3) . The mean goblet cell numbers/10( rim' in histologically normal mucosa were not significantly different from those in untreated coeliac mucosa being 358 (22.3) and 388 (24) respectively. When goblet cell numbers were expressed per unit length of epithelium (10 mm), the mean cell number in untreated coeliac mucosa (299.5 (13.9)) was significantly higher (p<O-Ol) than that of histologically normal mucosa (223.5 (12.9)).
Discussion
The results show that over 24 hours culture in vitro, untreated coeliac mucosa synthesises and secretes greater quantities of glycoproteins than histologically normal jejunal mucosa. The use of radiolabelled sugars to measure gastrointestinal glycoprotein production is a well established technique7`i' and is thought largely to be an indication of mucus glycoprotein secretion. 4 The results of this study show a significant correlation between 'H glucosamine incorporation into glycoproteins in histologically normal tissue and goblet cell numbers/I1)" rm' mucosa in individual patients. Whilst the number of goblet cells per unit length of epithelium was significantly increased in untreated coeliac mucosa, the changes in surface to mucosal area ratio associated with villous atrophy resulted in no marked increases in goblet cell number when expressed per unit area of mucosa. These observations suggest that the increased glucosamine incorporation in untreated mucosa (expressed as dpm/mg biopsy protein) could in part be a result of an increase in the rate of mucus glycoprotein biosynthesis at the cellular level. While local immunoglobulin production is increased in coeliac disease,"' the extent of glycosylation of immunoglobulins is unlikely to account for the markedly increased incorporation of H glucosamine into glycoproteins over the 24 hour culture period. Alternatively, the differences in incorporation could reflect chaniges in precursor pool sizes, with histologically normal mucosa having a larger intracellular pool of tinlabelled glucosamine. Free glucosamine, however, had not been found in intestinal tissue.
Several immunological factors could contribute to the enhanced secretion of radiolabelled glycoproteins observed in untreated coeliac patients.
Immune complexes," macrophage products' and the anaphylatoxin C3a`have all been shown to stimulate mucus glycoprotein secretion by intestinal or pulmonary tissue. T lymphocytes have also been implicated in intestinal goblet cell hyperplasia in helminth infections in rats.
The increased activation of T lymphocytes in untreated coeliac mucosa"' may induce changes in goblet cell maturation or differentiation. T lymphocyte products have recently been shown to modify epithelial differentiation, enhancing the expression of HLA-DR on intestinal epithelial cell lines-and fetal intestinal epithelium" in vitro.
The basal rate of mucus secretion can also be modified by endogenous neurotransmitters -for example, acetylcholine,' and vasoactive amines such as 5-hydroxytryptamine&" as well as numerous external secretagogues.
Whilst our results show quantitative changes in mucus glycoprotein secretion in untreated coeliac mucosa, relatively little is known about the biochemical nature of mucus in coeliac disease. Certainly in untreated patients there is an increase in intestinal permeability,"' suggesting that the enhanced mucus secretion does not impede the uptake of marker molecules. A recent histological study has reported changes in lectin binding characteristics of goblet cells of children with coeliac disease, implying alterations in oligosaccharide side chains of mucus glycoproteins."-In situations in which increased mucus glycoprotein secretion is observed, qualitative changes in the released mucus frequently occur. This, therefore, may have direct relevance to the pathogenesis of coeliac disease, accounting for the observed increase in intestinal permeability and perhaps also some of the recognised immune abnormalities in this condition. 
